In a report published Tuesday, Oppenheimer analysts initiated coverage on La Jolla Pharmaceutical Co. (LJPC) with an ‘Outperform‘ rating and $43 price target.
On valuation measures, La Jolla Pharmaceutical Co. shares currently have a PEG ratio of (0.66). EPS for the same period is ($2.00). Currently there are 3 analysts that rate LJPC a ‘Buy’. No analyst rates it a ‘Hold’ or a ‘Sell’. LJPC has a median Wall Street price target of $29.00 with a high target of $54.00.
In the past 52 weeks, shares of San Diego, California-based biopharmaceutical company have traded between a low of $6.17 and a high of $24.89 and are now at $22.09. Shares are up 90.32% year-over-year and 3.36% year-to-date.
Investment analysts at Northland Capital initiated coverage on shares of SolarCity Corporation (SCTY) in a note issued to investors on Tuesday. The firm set an ‘Outperform‘ rating and a $65 price target on the stock. The firm’s price target would suggest a potential upside of about 14% from the stock’s current price of $57.26.
SolarCity Corp., currently valued at $5.53 billion, has a median Wall Street price target of $80.50 with a high target of $98.00. Approximately 1.42 million shares have changed hands as of 2:29 pm EDT, compared to the stock’s average daily volume of 2.44 million.
In the past 52 weeks, shares of the manufacturer of solar energy systems have traded between a low of $45.79 and a high of $79.40 with the 50-day MA and 200-day MA located at $51.76 and $52.70 levels, respectively. Additionally, shares of SCTY have a Relative Strength Index (RSI) and MACD indicator of 65.65 and +1.70, respectively.
SolarCity Corp. currently prints a year-to-date return of around 6%.
Shares of HubSpot, Inc. (HUBS) are up 2.88% at $40.77, after Needham analysts today initiated coverage of the name, giving it a ‘Buy‘ rating and price target of $50.
HubSpot, Inc’s current year and next year EPS growth estimates stand at 62.50% and 21.20% compared to the industry growth rates of 17.90% and 21.60%, respectively. Ticker has a t-12 price/sales ratio of 11.03. EPS for the same period registers at ($4.20).
HUBS’ shares have declined 6.27% in the last 4 weeks and advanced 18.92% in the past three months. Over the past 5 trading sessions the stock has gained 2.17%. Shares of HubSpot, Inc. are up 17.82% this year.
Oppenheimer is out with a report this morning initiating coverage of Geron Corporation (GERN) with an ‘Outperform‘ rating and $5.50 price target, implying 29% expected return.
In the past 52 weeks, shares of Cambridge, Massachusetts-based cloud provider have traded between a low of $1.60 and a high of $4.49 and are now trading at $4.27. Shares are up 125.78% year-over-year and 27.38% year-to-date.
Cantor Fitzgerald initiated shares of Lumber Liquidators Holdings, Inc. (LL) with a ‘Buy‘ rating on the name. Right now, the stock is sitting at $33.44, a 3.72% gain, and is 51.38% lower year-to-date, compared with an 11.75% gain in the S&P 500.
LL closed Monday at $32.24. The company has a total market cap of 904.65 million.